ESG EKO AGRO Italia is a fully owned subsidiary of ESGTI AG. A direct participation is therefore currently not possible. Interested investors please find information here.

Investing in ESGTI Group means impact, ESG and green investing.

Impact investing

Impact investing refers to investments “made into companies, organizations, and funds with the intention to generate a measurable, beneficial social or environmental impact alongside a financial return”. Impact investments provide capital to address social and/or environmental issues.

Investing in an esg company

Environmental, social and corporate governance refers to the three central factors in measuring the sustainability and ethical impact of an investment in a company or business.

Green investing

Green investing refers to investing activities aligned with a commitment to the promotion of environmentally friendly business practices and the conservation of natural resources.

Recent Updates
from ESGTI

Bond issuance planned! ESGTI, in collaboration with Aldburg S.A., Luxembourg, will shortly issue a EUR 250,000,000 6% Fixed Rate Bond mainly for the financing of ESG EKO AGRO’s projects.

On April 7, 2020, ESGTI’s Board of Directors announced that the first tranche of the approved ordinary capital increase has been completed by subscriptions of 13,752,438 registered shares with a nominal value of CHF 1.56 each for at an issue price of CHF 4 per share. The current share capital of ESGTI AG thus amounts to CHF 29,838,803.28.

ESGTI’s Board of Directors was also strengthened with three highly experienced members: Dimitri F. Dimitriou, Wolfgang H. Werlé and Hermann A. Wirz.

Mr Dimitriou has 30 years’ experience in the pharmaceutical and biotech industry. He is a co-founder and CEO of ImmuPharma plc, a biotech company listed on AIM of the London Stock Exchange since 2006. His past roles include Senior Director, Worldwide Business Development at GlaxoSmithKline, where his responsibilities included worldwide corporate deals with pharmaceutical and biotech companies. He held a similar role in Europe for Bristol-Myers Squibb. Prior to that, he spent 8 years at Procter & Gamble in senior marketing, R&D and business development positions and began his career in marketing at Novartis in 1987. He is also the founder and President of Dragon Finance AG (Zurich) and DyoDelta Biosciences Ltd. (London), two advisory companies specialising in life sciences. He has two degrees from the University of London – a Bachelor’s in Biochemistry from Kings College and a Master’s in Pathology from Imperial College Medical School. He is a Member of the British Pharmacological Society, the British Neuroscience Association, the British Society for Immunology, and a Fellow of the Royal Society of Chemistry, the Royal Society of Biology and the Institute of Biomedical Science.

Mr Werlé is the Founder of the international investments company Quantrum AG with over 20 years’ experience on the Boards of companies in a range of industries, including food and catering, medical tourism and luxury hospitality, and asset management. Currently Mr Werlé serves as Vice-Chairman of Nimo Holding AG; Chairman of Asserta Management AG and of Grand Resort Bad Ragaz AG. He is also a Member of the Board of Directors of Cat Holding AG and FORMIA Asia Pacific (a Hong-Kong based company). Past positions include: Board member of Swiss Post, Vice-Chairman of the speciality food company Aryzta (2008), CEO of the Hiestand Group and of AirRelations. Mr Werlé Studied Business Management at the University of Applied Sciences of Frankfurt/Main, Germany and began his career at Deutsche Lufthansa AG.

Mr Wirz can look back over a 40-year career with Nestlé Group in different positions of responsibility, including leadership roles in finance, accounting and operations in a number of South American countries, the UK and Spain. He served as Chief Financial Officer and Senior Vice President of Nestlé S.A, Switzerland and was a Director of Nestlé Health Science S.A. Past positions also include Board member of Nestlé Capital Advisers, Intercona Reinsurance AG, Alcon Inc. (US listed) and SIX (Swiss Stock Exchange). Currently Mr Wirz serves as Director and Head of the Audit Committee of SICPA Holding SA. Mr Wirz obtained a BA in Business Administration from Lucerne, and completed the Programme for Executive Development at the International Institute for Management Development (IMD), Lausanne.

ESGTI share price

One year YTD